Amiodarone-induced pulmonary mass and cutaneous vasculitis

21 Schroter-Kunhardt M. Nah—Todeserfahrungen aus psychiatrischneurologischer Sicht. In: Knoblaub H, Soeffner HG, eds. Todesnahe: interdisziplinare Zugange zu einem ausergewohnlichen Phanomen. Konstanz: Universitatsverlag Konstanz, 1999: 65–99. 22 Sabom MB. Light and death: one doctors fascinating account of near-death experiences. Michigan: Zondervan Publishing House, 1998: 37–52. 23 Penfield W. The excitable cortex in conscious man. Liverpool: Liverpool University Press, 1958. 24 Meduna LT. Carbon dioxide therapy: a neuropsychological treatment of nervous disorders. Springfield: Charles C Thomas, 1950. 25 Whinnery JE, Whinnery AM. Acceleration-induced loss of consciousness. Arch Neurol 1990; 47: 764–76. 26 Jansen K. Neuroscience, ketamine and the near-death experience: the role of glutamate and the NMDA-receptor. In: Bailey LW, Yates J, eds. The near-death experience: a reader. New York and London: Routledge, 1996: 265–82. 27 Greyson B. Biological aspects of near-death experiences. Perspect Biol Med 1998; 42: 14–32. 28 Grof S, Halifax J. The human encounter with death. New York: Dutton, 1977. 29 Clute HL, Levy WJ. Electroencephalographic changes during brief cardiac arrest in humans. Anesthesiology 1990; 73: 821–25. 30 Aminoff MJ, Scheinman MM, Griffing JC, Herre JM. Electrocerebral accompaniments of syncope associated with malignant ventricular arrhythmias. Ann Intern Med 1988; 108: 791–96. 31 Ring K, Cooper S. Mindsight: near-death and out-of-body experiences in the blind. Palo Alto: William James Center for Consciousness Studies, 1999. ARTICLES